Listed

Milestone Scientific Inc.: Form 10-Q for the period ended Sep 30, 2014

Filed with the SEC on Nov 13, 2014 and accepted by EDGAR at Nov 13, 2014, 17:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-07-01 to 2014-09-30$2.5mus-gaap:SalesRevenueGoodsNet
Revenue9 months2014-01-01 to 2014-09-30$7.7mus-gaap:SalesRevenueGoodsNet
Cost of revenue3 months2014-07-01 to 2014-09-30$829.5kus-gaap:CostOfGoodsSold
Cost of revenue9 months2014-01-01 to 2014-09-30$2.6mus-gaap:CostOfGoodsSold
Gross profit3 months2014-07-01 to 2014-09-30$1.7mus-gaap:GrossProfit
Gross profit9 months2014-01-01 to 2014-09-30$5.0mus-gaap:GrossProfit
Research and development3 months2014-07-01 to 2014-09-30$29.4kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2014-01-01 to 2014-09-30$74.3kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2014-07-01 to 2014-09-30$1.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2014-01-01 to 2014-09-30$4.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-07-01 to 2014-09-30−$162.2kus-gaap:OperatingIncomeLoss
Operating income9 months2014-01-01 to 2014-09-30$214.5kus-gaap:OperatingIncomeLoss
Net income3 months2014-07-01 to 2014-09-30−$358.5kus-gaap:NetIncomeLoss
Net income9 months2014-01-01 to 2014-09-30−$333.1kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-07-01 to 2014-09-30−$0.02us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2014-01-01 to 2014-09-30−$0.02us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-07-01 to 2014-09-30−$0.02us-gaap:EarningsPerShareBasic
Basic EPS9 months2014-01-01 to 2014-09-30−$0.02us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-07-01 to 2014-09-3021,189,245 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2014-01-01 to 2014-09-3019,621,471 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2014-01-01 to 2014-09-30−$3.4kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2014-01-01 to 2014-09-30$66.1kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-09-30$781.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-09-30$15.6mus-gaap:AssetsCurrent
Total assetsAt period end2014-09-30$17.3mus-gaap:Assets
Current liabilitiesAt period end2014-09-30$2.0mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-09-30$15.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-14-005667. Last ingested by Listed: Nov 14, 2026, 11:14 ET. Listed shows no prices and gives no investment advice.